The New York Times published an op-ed by U.S. Congressman
Andy Harris (R-MD 1st District) in which he proposes a policy
solution for the problem of, not enough innovative thinking to optimize the value
of dollars spent on biomedical research. Harris presents a
fairly disparaging picture of the National Institutes of Health (NIH) and its
poor ability to administer the money that Congress appropriates each year. Whether this claim is true or not, one of his
criticisms in particular is that NIH is funding the wrong people, investigators
who, “though well-regarded in their fields,” are too old to make particularly
valuable contributions to science.
One of Congressman
Harris’s more clearly defined solutions is based on an over-simplified problem
definition, which presumes an inverse relationship between an investigator’s
age and her propensity to produce innovative discoveries. According to this framework, his proposed
policy solution is to increase the value of dollars Congress allocates for
biomedical research by lowering the average age of NIH investigators. The sole basis for this solution rests on the
results of a single study published by the National
Bureau of Economic Research (NBER) entitled, Age and Great Invention (Jones, 2005).
It is strikingly
noteworthy that The Review of Economics and Statistics published
a peer-reviewed version of this study (Jones, 2010) and concluded--in
the abstract--that, "innovators have become especially unproductive at
younger ages.” Furthermore, the Harris solution to increasing scientific
productivity subtly and erroneously presumes that the relationship between age
and productivity is causal. In other
words, young age causes productivity. The
NBER study does not seem to provide any empirical evidence to support that
claim. A more accurate interpretation
suggests that the average age of “great innovation has trended upwards by
approximately 6 years over the course of the 20th Century” (Jones,
2005, p. 17), and reasonably so, because the demand for increasing time
requirements of education and knowledge acquisition functions as an opportunity
cost of preparing aspiring great achievers to produce. Given a more accurate interpretation of
empirical observations, alternative funding policies would have a greater
probability of producing desired results by incorporating evidence of the
trade-off between training investment and age at time of great achievements.
Too often, policy
formulation is based on belief, custom, and a need to do something rather than an in-depth understanding about the true
nature of the problem. In the matter of
how to promote and ensure innovative productivity in biomedical research, a truly
wise and potentially more effective solution would be to invest increased
resources in and attribute greater value to policy research and evaluation
efforts designed to determine which factors and circumstances predict
production of research discoveries that lead to marketable discoveries that are
capable of improving public health.
Congressman Harris’s statements illustrate the inherent disconnect
between policy research and how its results get haphazardly translated into quick-fix
policy solutions with little promise for influencing desirable outputs. It also points out the importance of defining
a public problem succinctly and rationally, using empirical evidence as a
guide.
Here's another point worth noting: Andy Harris will be sitting on the Labor Subcommittee of the House Appropriations Committee this fall. There's a god chance that his proposed policy will become a reality, or at the very least, a total nightmare for those bureaucrats charged with preparing talking points for the upcoming budget hearings.
Here's another point worth noting: Andy Harris will be sitting on the Labor Subcommittee of the House Appropriations Committee this fall. There's a god chance that his proposed policy will become a reality, or at the very least, a total nightmare for those bureaucrats charged with preparing talking points for the upcoming budget hearings.
No comments:
Post a Comment